SAN RAFAEL, Calif., May 2, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in Deutsche Bank's 42(nd) Annual Health Care Conference on May 3, 2017 at 9:20am ET, in Boston and the Bank of America Merrill Lynch 2017 Health Care Conference on May 16, 2017 at 1:40pm PT/4:40pm ET, in Las Vegas. To access the live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.



    Contacts:

    Investors                    Media

    Traci McCarty                Debra Charlesworth

    BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc.

    (415) 455-7558               (415) 455-7451

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biomarin-to-attend-two-upcoming-investor-conferences-300449079.html

SOURCE BioMarin Pharmaceutical Inc.